Study suggests aspirin may reduce risk of melanoma
A new Stanford University study suggests taking aspirin may reduce the risk of melanoma in women.
Researchers looked at nearly 60,000 postmenopausal women for 12 years in the largest study of its kind. They found the women who took regular doses of aspirin lowered their risk of getting melanoma by at least 20 percent.
Researchers believe inflammation plays a big role in cancer development and aspirin is an anti-inflammatory drug. But they caution that an aspirin a day won't keep melanoma away.
The study can be found in the journal Cancer.
stanford university, cancer, medical research, health
- SF firefighters continue to monitor 5-alarm fire
- Lawmakers call for changes after refinery acid spill
- San Jose police officer facing rape charges
- Feinstein: CIA improperly searched computer network
- Driver arrested after officer finds 128lbs of pot in van
- 49ers acquire Jonathan Martin from Dolphins
- Malaysian military says missing jet changed course
- Two students arrested for making dog drink beer
- Pedestrian hit by car in downtown San Francisco crosswalk
- Pavelski scores twice as Sharks beat Leafs 6-2
- Warriors whip Mavs 108-85 for 5th straight win
- roundup: Bay Area winds; Great Highway closure
- abcnews: 'The Bachelor' Finale Full Recap
- weather: Bay Area weather forecast for Wednesday
Most Viewed StoriesMost Viewed Photos